Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 41-49 of 49
Item hits:
Issue DateTitleAuthor(s)
9-Aug-2017Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, T; De Silva, D; Ennis, D; Piskorz, A, et al
13-Aug-2018Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, TE; De Silva, D; Ennis, D; Piskorz, AM, et al
1-Jul-2018Biomarker assessment of HR deficiency, tumor BRCA1/2 mutations and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapyStronach, EA; Paul, J; Timms, KM; Hughes, E; Brown, K, et al
1-Sep-2010The RNA binding protein Larp1 regulates cell division, apoptosis and cell migrationBurrows, C; Latip, NA; Lam, S-J; Carpenter, L; Sawicka, K, et al
9-Aug-2012Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancerHarding, V; Fenu, E; Medani, H; Shaboodien, R; Ngan, S, et al
11-Jul-2011Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancerSharma, R; Graham, J; Blagden, S; Gabra, H
1-Dec-2014Introduction to managing patients with recurrent ovarian cancerGabra, H
1-Aug-2018The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerAntony, J; Zanini, E; Kelly, Z; Tan, TZ; Karali, E, et al
1-Aug-2018Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ruscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M, et al